4.4 Article

Role of Molecular Genetics in Hemophilia: From Diagnosis to Therapy

Journal

SEMINARS IN THROMBOSIS AND HEMOSTASIS
Volume 38, Issue 1, Pages 64-78

Publisher

THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0031-1300953

Keywords

hemophilia; genetic diagnosis; phenotype; variation; inhibitor; gene therapy

Funding

  1. Department of Science of Technology, Government of India
  2. Department of Biotechnology, Government of Indi [2010-BT/03/IYBA/2010, BT/PR14748/MED/12/491/2010]
  3. Bayer Hemophilia Awards Program, Bayer Inc.

Ask authors/readers for more resources

Despite significant advancements, state-of-the-art care remains inaccessible to patients with hemophilia, especially those from developing countries. Thus, innovative approaches in the management of this condition are needed to improve their quality of life. In this context, genetic studies in hemophilia have contributed to the better understanding of its biology, the detection of carriers, and prenatal diagnosis, and even fostering newer therapeutic strategies. This article reviews the applications of molecular genetics in hemophilia, in general, and how such techniques can be useful for optimizing patient care, in particular.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available